Sekar Kathiresan
Chief Executive Officer, Founder @Verve Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer, Founder @Verve Therapeutics
US
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to treat coronary artery disease, the most common type of heart disease and the leading cause of death worldwide. Verve brings together two of the biggest breakthroughs in 21st century biomedicine — human genetic analysis and gene editing — to realize a new future, one of longevity and vitality for tens of millions of people worldwide suffering from coronary artery disease.
EDUCATION
Massachusetts General Hospital
Cardiovascular Medicine Fellowship Training Program
University of Pennsylvania
Bachelor of Arts - BA, History, Summa Cum Laude
Massachusetts General Hospital
Chief Resident, Internal Medicine
Massachusetts General Hospital
Internal Medicine Residency Program
Broad Institute
Post-doctoral Fellowship, human genetics
Framingham Heart Study
Postdoctoral Research Fellow, Genetic epidemiology
ABOUT SEKAR KATHIRESAN
At Verve, we are focused on developing therapies that safely edit the adult human genome to treat heart attack. I come to Verve via learning cardiology at Harvard Medical School and deciphering the genomic basis for risk and resistance to heart attack at the Broad Institute and Massachusetts General Hospital.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.